Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells
Open Access
- 14 September 2009
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 100 (10) , 1885-1894
Abstract
An elevated serum level of NM23‐H1 protein is found in acute myelogenous leukemia (AML), and predicts a poor treatment outcome in AML patients. To investigate the potential pathological link between the elevated serum level of this protein and poor prognosis, we examined the extracellular effects of recombinant NM23‐H1 protein on the in vitro growth and survival of primary cultured AML cells at concentrations equivalent to the levels found in the serum of AML patients. Extracellular NM23‐H1 protein promoted the in vitro growth and survival of AML cells and this activity was associated with the cytokine production and activation of the MAPK and signal transducers and activators of transcription signaling pathways. Inhibitors specific to MAPK signaling pathways inhibited the growth‐ and survival‐promoting activity of NM23‐H1. These findings indicate the novel biological action of extracellular NM23‐H1 and its association with poor prognosis, and suggest an important role for extracellular NM23‐H1 in the malignant progression of leukemia and a potential therapeutic target for these malignancies. (Cancer Sci 2009; 100: 1885–1894)Keywords
This publication has 31 references indexed in Scilit:
- Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinaseBritish Journal of Cancer, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2Cancer Research, 2007
- Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responsesNature Reviews Immunology, 2004
- Serum nm23-H1 Protein as a Prognostic Factor in Hematological MalignanciesLeukemia & Lymphoma, 2002
- Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylationCell, 1995
- The potential roles of nm23 in cancer metastasis and cellular differentiationEuropean Journal of Cancer, 1995
- Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinaseBiochemical and Biophysical Research Communications, 1992
- Overexpression of nucleoside diphosphate kinase (nm23) in solid tumoursEuropean Journal of Cancer and Clinical Oncology, 1991